Responsive Cortical Stimulation for the Treatment of Epilepsy

Felice T. Sun, Martha J. Morrell, Robert E. Wharen

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

Epilepsy is a common chronic neurological disorder affecting ∼1-2% of the population. Despite the available treatment options (pharmacotherapy, surgery, and vagus nerve stimulation), a large percentage of patients continue to have seizures. With the success of deep brain stimulation for treatment of movement disorders, brain stimulation has received renewed attention as a potential treatment option for epilepsy. Responsive stimulation aims to suppress epileptiform activity by delivering stimulation directly in response to electrographic activity. Animal and human data support the concept that responsive stimulation can abort epileptiform activity, and this modality may be a safe and effective treatment option for epilepsy. Responsive stimulation has the advantage of specificity. In contrast to the typically systemic administration of pharmacotherapy, with the concomitant possibility of side effects, electrical stimulation can be targeted to the specific brain regions involved in the seizure. In addition, responsive stimulation provides temporal specificity. Treatment is provided as needed, potentially reducing the likelihood of functional disruption or habituation due to continuous treatment. Here we review current animal and human research in responsive brain stimulation for epilepsy and then discuss the NeuroPace RNS System, an investigational implantable responsive neurostimulator system that is being evaluated in a multicenter, randomized, double-blinded trial to assess the safety and efficacy of responsive stimulation for the treatment of medically refractory epilepsy.

Original languageEnglish (US)
Pages (from-to)68-74
Number of pages7
JournalNeurotherapeutics
Volume5
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Epilepsy
Implantable Neurostimulators
Therapeutics
Brain
Seizures
Vagus Nerve Stimulation
Drug Therapy
Deep Brain Stimulation
Movement Disorders
Nervous System Diseases
Electric Stimulation
Safety
Population

Keywords

  • closed-loop
  • device
  • Epilepsy
  • neurostimulation
  • responsive stimulation

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Responsive Cortical Stimulation for the Treatment of Epilepsy. / Sun, Felice T.; Morrell, Martha J.; Wharen, Robert E.

In: Neurotherapeutics, Vol. 5, No. 1, 01.2008, p. 68-74.

Research output: Contribution to journalArticle

Sun, Felice T. ; Morrell, Martha J. ; Wharen, Robert E. / Responsive Cortical Stimulation for the Treatment of Epilepsy. In: Neurotherapeutics. 2008 ; Vol. 5, No. 1. pp. 68-74.
@article{04adc00f7f0645008e996f9151823400,
title = "Responsive Cortical Stimulation for the Treatment of Epilepsy",
abstract = "Epilepsy is a common chronic neurological disorder affecting ∼1-2{\%} of the population. Despite the available treatment options (pharmacotherapy, surgery, and vagus nerve stimulation), a large percentage of patients continue to have seizures. With the success of deep brain stimulation for treatment of movement disorders, brain stimulation has received renewed attention as a potential treatment option for epilepsy. Responsive stimulation aims to suppress epileptiform activity by delivering stimulation directly in response to electrographic activity. Animal and human data support the concept that responsive stimulation can abort epileptiform activity, and this modality may be a safe and effective treatment option for epilepsy. Responsive stimulation has the advantage of specificity. In contrast to the typically systemic administration of pharmacotherapy, with the concomitant possibility of side effects, electrical stimulation can be targeted to the specific brain regions involved in the seizure. In addition, responsive stimulation provides temporal specificity. Treatment is provided as needed, potentially reducing the likelihood of functional disruption or habituation due to continuous treatment. Here we review current animal and human research in responsive brain stimulation for epilepsy and then discuss the NeuroPace RNS System, an investigational implantable responsive neurostimulator system that is being evaluated in a multicenter, randomized, double-blinded trial to assess the safety and efficacy of responsive stimulation for the treatment of medically refractory epilepsy.",
keywords = "closed-loop, device, Epilepsy, neurostimulation, responsive stimulation",
author = "Sun, {Felice T.} and Morrell, {Martha J.} and Wharen, {Robert E.}",
year = "2008",
month = "1",
doi = "10.1016/j.nurt.2007.10.069",
language = "English (US)",
volume = "5",
pages = "68--74",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Responsive Cortical Stimulation for the Treatment of Epilepsy

AU - Sun, Felice T.

AU - Morrell, Martha J.

AU - Wharen, Robert E.

PY - 2008/1

Y1 - 2008/1

N2 - Epilepsy is a common chronic neurological disorder affecting ∼1-2% of the population. Despite the available treatment options (pharmacotherapy, surgery, and vagus nerve stimulation), a large percentage of patients continue to have seizures. With the success of deep brain stimulation for treatment of movement disorders, brain stimulation has received renewed attention as a potential treatment option for epilepsy. Responsive stimulation aims to suppress epileptiform activity by delivering stimulation directly in response to electrographic activity. Animal and human data support the concept that responsive stimulation can abort epileptiform activity, and this modality may be a safe and effective treatment option for epilepsy. Responsive stimulation has the advantage of specificity. In contrast to the typically systemic administration of pharmacotherapy, with the concomitant possibility of side effects, electrical stimulation can be targeted to the specific brain regions involved in the seizure. In addition, responsive stimulation provides temporal specificity. Treatment is provided as needed, potentially reducing the likelihood of functional disruption or habituation due to continuous treatment. Here we review current animal and human research in responsive brain stimulation for epilepsy and then discuss the NeuroPace RNS System, an investigational implantable responsive neurostimulator system that is being evaluated in a multicenter, randomized, double-blinded trial to assess the safety and efficacy of responsive stimulation for the treatment of medically refractory epilepsy.

AB - Epilepsy is a common chronic neurological disorder affecting ∼1-2% of the population. Despite the available treatment options (pharmacotherapy, surgery, and vagus nerve stimulation), a large percentage of patients continue to have seizures. With the success of deep brain stimulation for treatment of movement disorders, brain stimulation has received renewed attention as a potential treatment option for epilepsy. Responsive stimulation aims to suppress epileptiform activity by delivering stimulation directly in response to electrographic activity. Animal and human data support the concept that responsive stimulation can abort epileptiform activity, and this modality may be a safe and effective treatment option for epilepsy. Responsive stimulation has the advantage of specificity. In contrast to the typically systemic administration of pharmacotherapy, with the concomitant possibility of side effects, electrical stimulation can be targeted to the specific brain regions involved in the seizure. In addition, responsive stimulation provides temporal specificity. Treatment is provided as needed, potentially reducing the likelihood of functional disruption or habituation due to continuous treatment. Here we review current animal and human research in responsive brain stimulation for epilepsy and then discuss the NeuroPace RNS System, an investigational implantable responsive neurostimulator system that is being evaluated in a multicenter, randomized, double-blinded trial to assess the safety and efficacy of responsive stimulation for the treatment of medically refractory epilepsy.

KW - closed-loop

KW - device

KW - Epilepsy

KW - neurostimulation

KW - responsive stimulation

UR - http://www.scopus.com/inward/record.url?scp=37349050623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349050623&partnerID=8YFLogxK

U2 - 10.1016/j.nurt.2007.10.069

DO - 10.1016/j.nurt.2007.10.069

M3 - Article

C2 - 18164485

AN - SCOPUS:37349050623

VL - 5

SP - 68

EP - 74

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 1

ER -